{"id":"l-glutamine","_fda":{"id":"7c195150-c710-4d62-9d80-d1bdecd99e6a","set_id":"38fd4f98-a42a-435b-9643-16df66453951","openfda":{"nui":["N0000193618","M0001797","N0000185508","N0000175629","N0000184306","M0000728","M0000499","N0000175941","N0000000209","N0000000245","N0000175552","N0000175555","N0000175570","M0003647","N0000175780","M0000922","N0000185371","N0000185375","M0006342","M0016962"],"unii":["94ZLA3W45F","PQ6CK8PD0R","N9E3X5056Q","SQE6VB453K","S7UI8SM58A","0R0008Q3JB","26SK597UWV","RV823G6G67","K0U68Q2TXA","MU72812GK0","CI71S98N1Z","YKH834O4BH","39R4TAN1VT","0RH81L854J","2788Z9758H","9679TC07X4","GMW67QNF9C","02F3473H9O","T42NAD2KHC","9YY2F980SV","81AH48963U","7OV03QG267","E524N2IXA3","27YLU75U4W","660YQ98I10","12H3K5QKN9","H6241UJ22B","9N3UK29E57","451W47IQ8X","41YPU4MMCA","91D9GV0Z28","HG18B9YRS7","00J9J9XKDE","U6WSN5SQ1Z"],"route":["ORAL"],"spl_id":["7c195150-c710-4d62-9d80-d1bdecd99e6a"],"brand_name":["Recovatone"],"spl_set_id":["38fd4f98-a42a-435b-9643-16df66453951"],"package_ndc":["44911-0542-1"],"product_ndc":["44911-0542"],"generic_name":["GLYCYRRHIZA GLABRA, KALI MURIATICUM, KALI PHOSPHORICUM, IODIUM, ZINCUM GLUCONICUM, PHOSPHORUS, ASCORBICUM ACIDUM, CALCIUM GLUCONATE, L-ARGININE, L-CARNITINE, L-ORNITHINE, MAGNESIA MURIATICA, MAGNESIUM GLUCONICUM DIHYDRICUM, MANGANESE GLUCONATE, NATRUM MURIATICUM, COBALT GLUCONATE, COPPER GLUCONATE, CREATINE, L-GLUTAMINE, L-LEUCINE, L-VALINE, POTASSIUM GLUCONATE, SELENIUM DIOXIDE, ADRENALINUM, BORON, CALCAREA PHOSPHORICA, FERRUM SULPHURICUM, MOLYBDENUM, NICCOLUM METALLICUM, SELENIUM METALLICUM,"],"product_type":["HUMAN OTC DRUG"],"pharm_class_cs":["Ascorbic Acid [CS]","Allergens [CS]","Adrenocorticotropic Hormone [CS]","Catecholamines [CS]","Amino Acids [CS]","Dietary Proteins [CS]","Plant Proteins [CS]"],"pharm_class_pe":["Increased Histamine Release [PE]","Cell-mediated Immunity [PE]"],"substance_name":["ARGININE","ASCORBIC ACID","BORON","CALCIUM GLUCONATE","CARNITINE","CHROMIUM","COBALTOUS GLUCONATE","COPPER GLUCONATE","CORTICOTROPIN","CREATINE","DIBASIC POTASSIUM PHOSPHATE","EPINEPHRINE","FERROUS SULFATE","GLUTAMINE","GLYCYRRHIZA GLABRA","IODINE","LEUCINE","MAGNESIUM CHLORIDE","MAGNESIUM GLUCONATE","MANGANESE GLUCONATE","MOLYBDENUM","NICKEL","ORNITHINE","PHOSPHORUS","POTASSIUM CHLORIDE","POTASSIUM GLUCONATE","SELENIUM","SELENIUM DIOXIDE","SODIUM CHLORIDE","STRONTIUM CARBONATE","TRIBASIC CALCIUM PHOSPHATE","VALINE","VANADIUM","ZINC GLUCONATE"],"pharm_class_epc":["Vitamin C [EPC]","Standardized Chemical Allergen [EPC]","Adrenocorticotropic Hormone [EPC]","alpha-Adrenergic Agonist [EPC]","beta-Adrenergic Agonist [EPC]","Catecholamine [EPC]","Amino Acid [EPC]","Non-Standardized Food Allergenic Extract [EPC]","Non-Standardized Plant Allergenic Extract [EPC]"],"pharm_class_moa":["Adrenergic alpha-Agonists [MoA]","Adrenergic beta-Agonists [MoA]"],"manufacturer_name":["Energique, Inc."],"is_original_packager":[true]},"purpose":["INDICATIONS: May temporarily relieve symptoms associated with exertions, such as muscle pain, muscle weakness, trembling of limbs, and cramps.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"version":"2","warnings":["WARNINGS: If pregnant or breastfeeding, ask a health professional before use. Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away. Do not use if tamper evident seal is broken or missing. Store in a cool, dry place."],"questions":["QUESTIONS: Dist. by Energique, Inc., 201 Apple Blvd. Woodbine, IA 51579 800.869.8078"],"effective_time":"20241029","active_ingredient":["ACTIVE INGREDIENTS: (in each drop): 3.67% of Adrenalinum 10X, Adrenocorticotrophin 15C, Ascorbicum Acidum 6X, Boron 12X, Calcarea Phosphorica 12X, Calcium Gluconate 6X, Chromium 14X, Cobalt Gluconate 8X, Copper Gluconate 8X, Creatine 8X, Ferrous Sulphuricum 12X, L-Arginine 6X, L-Carnitine 6X, L-Glutamine 8X, L-Leucine 8X, L-Ornithine 6X, L-Valine 8X, Magnesia Muriatica 6X, Molybdenum 12X, Natrum Muriaticum 6X, Niccolum Metallicum 12X, Potassium Gluconate 8X, Selenium Metallicum 12X, Selenium Dioxide 8X, Strontium Carbonicum 12X, Vanadium Metallicum 12X, Zincum Gluconicum 8X; 0.10% of Glycyrrhiza Glabra 1X, Iodium 4X, Kali Muriaticum 2X, Kali Phosphoricum 3X, Magnesium Gluconicum Dihydricum 6X, Manganese Gluconate 6X, Phosphorus 5X, Zincum Gluconicum 4X."],"inactive_ingredient":["INACTIVE INGREDIENTS: Demineralized water, 20% Ethanol."],"indications_and_usage":["INDICATIONS: May temporarily relieve symptoms associated with exertions, such as muscle pain, muscle weakness, trembling of limbs, and cramps.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated."],"dosage_and_administration":["DIRECTIONS: Adults and children take four droppers full twice a day for stamina building and muscle recovery; best if taken 1/2 hour prior to workout. For more strenuous workouts, dosage may be increased to eight droppers full. Consult a physician for use in children under 12 years of age."],"spl_product_data_elements":["Recovatone Glycyrrhiza Glabra, Kali Muriaticum, Kali Phosphoricum, Iodium, Zincum Gluconicum, Phosphorus, Ascorbicum Acidum, Calcium Gluconate, L-Arginine, L-Carnitine, L-Ornithine, Magnesia Muriatica, Magnesium Gluconicum Dihydricum, Manganese Gluconate, Natrum Muriaticum, Cobalt Gluconate, Copper Gluconate, Creatine, L-Glutamine, L-Leucine, L-Valine, Potassium Gluconate, Selenium Dioxide, Adrenalinum, Boron, Calcarea Phosphorica, Ferrum Sulphuricum, Molybdenum, Niccolum Metallicum, Selenium Metallicum, GLYCYRRHIZA GLABRA GLYCYRRHIZA GLABRA POTASSIUM CHLORIDE POTASSIUM CATION DIBASIC POTASSIUM PHOSPHATE PHOSPHATE ION IODINE IODINE ZINC GLUCONATE ZINC CATION PHOSPHORUS PHOSPHORUS ASCORBIC ACID ASCORBIC ACID CALCIUM GLUCONATE CALCIUM CATION ARGININE ARGININE CARNITINE CARNITINE ORNITHINE ORNITHINE MAGNESIUM CHLORIDE MAGNESIUM CATION MAGNESIUM GLUCONATE MAGNESIUM CATION MANGANESE GLUCONATE MANGANESE CATION (2+) SODIUM CHLORIDE CHLORIDE ION COBALTOUS GLUCONATE COBALTOUS CATION COPPER GLUCONATE CUPRIC CATION CREATINE CREATINE GLUTAMINE GLUTAMINE LEUCINE LEUCINE VALINE VALINE POTASSIUM GLUCONATE POTASSIUM CATION SELENIUM DIOXIDE SELENIUM DIOXIDE EPINEPHRINE EPINEPHRINE BORON BORON TRIBASIC CALCIUM PHOSPHATE CALCIUM CATION FERROUS SULFATE FERROUS CATION MOLYBDENUM MOLYBDENUM NICKEL NICKEL SELENIUM SELENIUM STRONTIUM CARBONATE STRONTIUM CATION VANADIUM VANADIUM CHROMIUM CHROMIUM CORTICOTROPIN CORTICOTROPIN WATER ALCOHOL"],"keep_out_of_reach_of_children":["KEEP OUT OF REACH OF CHILDREN: Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away."],"package_label_principal_display_panel":["PACKAGE LABEL DISPLAY: ENERGIQUE SINCE 1987 HOMEOPATHIC REMEDY RECOVATONE 4 fl. oz. (120 ml) Recovatone"]},"safety":{"boxedWarnings":[]},"_chembl":null,"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=L-glutamine","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T07:02:27.456406+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T07:02:33.163240+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=L-glutamine","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T07:02:33.487807+00:00"},"mechanism.drugClass":{"url":"https://api.fda.gov/drug/label.json","method":"deterministic","source":"FDA Label (EPC)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T07:02:26.321530+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T07:02:26.321557+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (no boxed warning)","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T07:02:26.321561+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL3707366/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T07:02:34.842351+00:00"}},"_dailymed":{"setId":"ad5728b6-d9de-4eac-8a2f-923ddf983c7d","title":"L-GLUTAMINE HIGH 7406 (L-GLUTAMINE HIGH) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]"},"mechanism":{"drugClass":"Vitamin C [EPC]"},"_scrapedAt":"2026-03-27T23:51:20.928Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T07:02:36.841606+00:00","fieldsConflicting":0,"overallConfidence":0.95},"trialDetails":[{"nctId":"NCT06617182","phase":"PHASE2","title":"Efficacy and Safety of Thalidomide Combined With Glutamine in the Treatment of Radiation Intestinal Injury.","status":"RECRUITING","sponsor":"Yongquan Shi","startDate":"2024-09-30","conditions":"Radiation Enteritis","enrollment":150},{"nctId":"NCT06883422","phase":"NA","title":"Pre-Surgical Immunonutrition's Effect on Colorectal Surgery","status":"RECRUITING","sponsor":"Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran","startDate":"2023-05-25","conditions":"Colorectal Surgery","enrollment":126},{"nctId":"NCT06031012","phase":"PHASE3","title":"Glutamine Combined With Thalidomide in Preventing Radiation-induced Oral Mucositis","status":"COMPLETED","sponsor":"Air Force Military Medical University, China","startDate":"2023-09-15","conditions":"Mucositis Oral","enrollment":138},{"nctId":"NCT07466758","phase":"PHASE2","title":"Personalized Pharmaconutrition Therapy for Myosteatosis, Sarcopenia, and Prognosis in Gastric Cancer Patients","status":"COMPLETED","sponsor":"Biruni University","startDate":"2024-10-16","conditions":"Myosteatosis, Sarcopenia","enrollment":40},{"nctId":"NCT07442084","phase":"NA","title":"Efficacy of Modified Si Ni San in Post-Polypectomy Management and Its Impact on Gut Microbiota in Colorectal Polyp Patients","status":"COMPLETED","sponsor":"Xi'an Hospital of Traditional Chinese Medicine","startDate":"2025-03-12","conditions":"Colorectal Polyps, Modified SiNiSan","enrollment":32},{"nctId":"NCT04735172","phase":"NA","title":"Exploration of Differences in Metabolite Concentrations by 7Teslas NMR Spectroscopy in Striatum and Subthalamic Nuclei in de Novo Parkinsonian Patients and Control Subjects","status":"RECRUITING","sponsor":"University Hospital, Clermont-Ferrand","startDate":"2022-04-07","conditions":"Parkinson's Disease","enrollment":44},{"nctId":"NCT03384108","phase":"NA","title":"In Vivo Assessment of Glutamine Utilization by Bone Marrow Plasma Cells","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2017-09-01","conditions":"Healthy","enrollment":20},{"nctId":"NCT07430202","phase":"PHASE1","title":"A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)","status":"NOT_YET_RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2026-05","conditions":"Liver Cancer (Fibrolamellar Hepatocellular Cancer (FLC))","enrollment":27},{"nctId":"NCT07039747","phase":"PHASE2","title":"Effectiveness of a Dietary Supplement in Irritable Bowel Syndrome","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2025-04-22","conditions":"Irritable Bowel Syndrome","enrollment":100},{"nctId":"NCT06291038","phase":"NA","title":"Efficacy of Glutamine Supplementation in Patients Suffering From Irritable Bowel Syndrome With Impaired Intestinal Permeability","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2024-10-03","conditions":"Irritable Bowel Syndrome","enrollment":60},{"nctId":"NCT07416747","phase":"NA","title":"GynMDD Add-On to Supportive Psychotherapy in Mild to Moderate Depression","status":"NOT_YET_RECRUITING","sponsor":"Fondation FondaMental","startDate":"2026-03","conditions":"Depression, Depression Disorder, Depression in Adults","enrollment":168},{"nctId":"NCT07220447","phase":"EARLY_PHASE1","title":"L-Theanine to Support Relaxation and Mood for Cancer Patients in Surveillance","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2026-04-01","conditions":"Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":50},{"nctId":"NCT06027086","phase":"PHASE1, PHASE2","title":"DRP-104 (Glutamine Antagonist) in Combination With Durvalumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC)","status":"RECRUITING","sponsor":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","startDate":"2024-02-12","conditions":"Fibrolamellar Hepatocellular Carcinoma","enrollment":27},{"nctId":"NCT04883515","phase":"NA","title":"Effects of Oral Glutamine Supplementation on Insulin Resistance and Functional Intestinal Disorders in Obese Patients.","status":"RECRUITING","sponsor":"University Hospital, Rouen","startDate":"2023-03-01","conditions":"Obesity, Insulin Resistance","enrollment":110},{"nctId":"NCT07390266","phase":"NA","title":"A Clinical Trial to Determine the Safety and Efficacy of an Origin Satiety Complex on Self-reported Hunger and Satiety in Healthy Adults","status":"NOT_YET_RECRUITING","sponsor":"Vora Life LLC","startDate":"2026-03","conditions":"High BMI, Hunger, Satiety","enrollment":30},{"nctId":"NCT05655819","phase":"PHASE1, PHASE2","title":"A Study of Glutamine to Treat Intestinal Permeability in Functional Dyspepsia","status":"COMPLETED","sponsor":"David J. Cangemi","startDate":"2023-02-16","conditions":"Functional Dyspepsia","enrollment":12},{"nctId":"NCT07020754","phase":"PHASE2","title":"Effect of Arginine- and Glutamine-based Oral Formulations on Salivary Biomarkers and Clinical Severity of Radiation-induced Oral Mucositis in Head and Neck Cancer: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2025-04-01","conditions":"Radiation Induced Oral Mucositis, Oral Mucositis, Oral Mucositis Due to Radiation","enrollment":84},{"nctId":"NCT04623502","phase":"NA","title":"An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy","status":"RECRUITING","sponsor":"University of Texas Southwestern Medical Center","startDate":"2019-09-30","conditions":"Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma","enrollment":600},{"nctId":"NCT03863457","phase":"PHASE1","title":"[18F] F-GLN by PET/CT in Breast Cancer","status":"RECRUITING","sponsor":"Abramson Cancer Center at Penn Medicine","startDate":"2019-04-05","conditions":"Breast Cancer","enrollment":40},{"nctId":"NCT05452889","phase":"EARLY_PHASE1","title":"PET Image in PAH Patients","status":"RECRUITING","sponsor":"Stephen Y. Chan","startDate":"2022-07-11","conditions":"Pulmonary Arterial Hypertension","enrollment":71},{"nctId":"NCT07347613","phase":"","title":"Long-term Follow-up of Diabetic Patients From the GLUTADIAB Study","status":"NOT_YET_RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2026-03-01","conditions":"Diabetes","enrollment":450},{"nctId":"NCT07155447","phase":"PHASE3","title":"Perioperative Nutrition Optimization for Reducing Complications After Surgical Fracture Fixation","status":"NOT_YET_RECRUITING","sponsor":"University of Minnesota","startDate":"2026-06-01","conditions":"Lower Extremity Fracture","enrollment":1000},{"nctId":"NCT03275974","phase":"PHASE1","title":"Glutamine PET Imaging Colorectal Cancer","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-04-27","conditions":"RAS Wild Type, Stage IV Colorectal Cancer, Stage IVA Colorectal Cancer","enrollment":6},{"nctId":"NCT06027242","phase":"NA","title":"Oral Supplementation of Glutamine on Gastric Cancer Patients After Gastrectomy","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2023-02-21","conditions":"Gastric Cancer, Immunonutrition, Gastrostomy","enrollment":120},{"nctId":"NCT07287592","phase":"PHASE3","title":"Glutamine for the Prophylaxis of Vincristine-induced Neuropathy in Children and Adolescents With Cancer.","status":"NOT_YET_RECRUITING","sponsor":"Ain Shams University","startDate":"2025-12-30","conditions":"Neuropathy, Cancer","enrollment":70},{"nctId":"NCT05972291","phase":"NA","title":"Mechanisms of Gulf War Illness","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2023-10-16","conditions":"Gulf War Illness, Irritable Bowel Syndrome, Gastrointestinal Symptoms","enrollment":80},{"nctId":"NCT04785989","phase":"","title":"In Vivo Metabolic Profiling of CLL (Chronic Lymphocytic Leukemia)","status":"RECRUITING","sponsor":"University of Wisconsin, Madison","startDate":"2022-06-13","conditions":"Chronic Lymphocytic Leukemia","enrollment":16},{"nctId":"NCT07249372","phase":"PHASE2","title":"DRP-104 in Patients With NFE2L2/KEAP1-altered Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"NYU Langone Health","startDate":"2025-12-01","conditions":"Non Small Cell Lung Cancer","enrollment":37},{"nctId":"NCT07211841","phase":"NA","title":"Correlative Analysis Between Magnetic Resonance Spectroscopy (MRS) and Essential Clinicobiological Data in Glioblatoma Multiforme (GBM)","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2025-12","conditions":"Glioblastoma, MRI Spectroscopy, Tumor Microenvironment","enrollment":30},{"nctId":"NCT01697930","phase":"PHASE1","title":"A Phase I Study: PET Imaging of Cancer Patients Using [18F] 4-L-Fluoroglutamine (2S,4R)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2012-09","conditions":"Solid Malignancy, Lymphoma","enrollment":67},{"nctId":"NCT07210450","phase":"PHASE2, PHASE3","title":"Effect of L-Glutamine on Pulmonary Artery Pressure in Patients With Non-Transfusion-Dependent Thalassemia","status":"COMPLETED","sponsor":"Mazandaran University of Medical Sciences","startDate":"2023-08-15","conditions":"Pulmonary Artery Pressure, Thalassemia, Non-transfusion Dependent Thalassemia","enrollment":8},{"nctId":"NCT05400733","phase":"NA","title":"Prandial Metabolic Phenotype in Adults","status":"RECRUITING","sponsor":"Texas A&M University","startDate":"2022-06-24","conditions":"Protein Metabolism","enrollment":50},{"nctId":"NCT02733120","phase":"NA","title":"Metabolic Processes in Adults and Adolescents With Autism Spectrum Disorder","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2015-12-03","conditions":"Autism Spectrum Disorder","enrollment":40},{"nctId":"NCT04634539","phase":"PHASE1","title":"Trial of First-line L-glutamine With Gemcitabine and Nab-paclitaxel in Advanced Pancreatic Cancer","status":"COMPLETED","sponsor":"Jun Gong, MD","startDate":"2021-05-13","conditions":"Advanced Pancreatic Adenocarcinoma, Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma","enrollment":18},{"nctId":"NCT06039384","phase":"PHASE1","title":"A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation","status":"TERMINATED","sponsor":"Incyte Corporation","startDate":"2023-12-28","conditions":"Advanced Solid Tumors","enrollment":6},{"nctId":"NCT06584448","phase":"NA","title":"Drinking, Acetate, and Stress","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-11-06","conditions":"Alcohol Use Disorder, Alcohol Use, Unspecified, Heavy Drinker","enrollment":50},{"nctId":"NCT07053761","phase":"PHASE2","title":"A Randomized Controlled Trial of Five - Flavor Sophora Flavescens Enteric - Coated Capsules for Radiation - Induced Proctitis After Pelvic Radiotherapy","status":"NOT_YET_RECRUITING","sponsor":"Peking University First Hospital","startDate":"2025-06-30","conditions":"Radiation - Induced Proctitis","enrollment":124},{"nctId":"NCT05827055","phase":"PHASE2","title":"Proglumide and Chemotherapy for Metastatic Pancreatic Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Georgetown University","startDate":"2024-01-31","conditions":"Metastatic Pancreatic Cancer","enrollment":30},{"nctId":"NCT06967428","phase":"PHASE2","title":"Effect of Metabolic Modulation on a Post-acute COVID-19 Vaccination Syndrome (PACVS) Cohort","status":"NOT_YET_RECRUITING","sponsor":"Independent Medical Alliance","startDate":"2025-09-01","conditions":"Vaccine Adverse Reaction, Post Acute Covid-19 Vaccination Syndrome","enrollment":100},{"nctId":"NCT05852990","phase":"PHASE3","title":"Glutamine Plus L. Reuteri Prevents TKI Therapy-diarrhea in Patients With NSCLC","status":"RECRUITING","sponsor":"Instituto Nacional de Cancerologia de Mexico","startDate":"2022-03-01","conditions":"Non-Small Cell Lung Cancer With EGFR Mutation","enrollment":28},{"nctId":"NCT05322135","phase":"EARLY_PHASE1","title":"A Pilot Study of Glutamine PET Imaging of Head and Neck Squamous Cell Carcinoma","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2022-09-14","conditions":"Head and Neck Squamous Cell Carcinoma, Head and Neck Cancer","enrollment":3},{"nctId":"NCT04353869","phase":"","title":"Targeting Glutamine Metabolism to Prevent Diabetic Cardiovascular Complications","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-11-16","conditions":"Glutamine, Diabetic, Cardiovascular Complications","enrollment":995},{"nctId":"NCT03461354","phase":"NA","title":"MucoLox Formulation to Mitigate Mucositis Symptoms in Head/Neck Cancer","status":"TERMINATED","sponsor":"Wake Forest University Health Sciences","startDate":"2018-04-09","conditions":"Mucositis Oral, Head and Neck Cancer","enrollment":49},{"nctId":"NCT02780219","phase":"NA","title":"Chronic Obstructive Pulmonary Disorder and Acute Exercise","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2016-02-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":57},{"nctId":"NCT06801951","phase":"NA","title":"Oral Supplement and Acute Resistance Exercise","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2017-12-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":16},{"nctId":"NCT03967795","phase":"NA","title":"Citrullinemia for the Prediction of Enteral Nutrition Tolerance Among Critically Ill Patients","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Besancon","startDate":"2019-11-28","conditions":"Enteral Nutrition, Intensive Care Unit, Biomarkers","enrollment":73},{"nctId":"NCT06764420","phase":"NA","title":"Effect of Arginine and Glutamine on Radiation-induced Oral Mucositis: a Trible Blinded Randomized Controlled Clinical Trial","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2023-05-20","conditions":"Radiation Mucositis, Head and Neck Cancer","enrollment":40},{"nctId":"NCT04233788","phase":"","title":"Metabolic Characterization of Space Occupying Lesions of the Brain","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2021-09-01","conditions":"Brain Tumor, Glioma, IDH Mutation","enrollment":55},{"nctId":"NCT04305769","phase":"PHASE2","title":"Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2021-06-01","conditions":"Clostridioides Difficile Infection, Clostridium Difficile Infection, Clostridium Difficile Diarrhea","enrollment":260},{"nctId":"NCT03263429","phase":"PHASE1, PHASE2","title":"Novel PET/CT Imaging Biomarkers of CB-839 in Combination With Panitumumab and Irinotecan in Patients With Metastatic and Refractory RAS Wildtype Colorectal Cancer","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2017-08-23","conditions":"Colorectal Cancer, Metastatic Colorectal Cancer, RAS Wild Type Colorectal Cancer","enrollment":29},{"nctId":"NCT03119883","phase":"NA","title":"Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2017-06-02","conditions":"Monoclonal Gammopathy of Undetermined Significance, Plasma Cell Myeloma","enrollment":35},{"nctId":"NCT06050668","phase":"PHASE2","title":"Essential Amino Acid Supplementation for Femoral Fragility Fractures","status":"RECRUITING","sponsor":"Michael C Willey","startDate":"2024-06-17","conditions":"Femoral Fracture, Fragility Fracture, Muscle Atrophy","enrollment":60},{"nctId":"NCT01347073","phase":"PHASE3","title":"Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-07","conditions":"Urea Cycle Disorders","enrollment":23},{"nctId":"NCT00947544","phase":"PHASE2","title":"Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-03","conditions":"Urea Cycle Disorders","enrollment":17},{"nctId":"NCT04693936","phase":"NA","title":"Metabolic Biomarkers in Hashimoto's Thyroiditis and Psoriasis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Crete","startDate":"2021-02-02","conditions":"Hashimoto Disease, Psoriasis","enrollment":200},{"nctId":"NCT05954923","phase":"NA","title":"The Glucagonotropic Effect of Amino Acids in Humans","status":"COMPLETED","sponsor":"University Hospital, Gentofte, Copenhagen","startDate":"2023-09-05","conditions":"Healthy","enrollment":12},{"nctId":"NCT05808010","phase":"NA","title":"Clinical Study of Umbilical Cord Blood Mononuclear Cell Therapy for the Treatment of Chronic Atrophic Gastritis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shandong Provincial Hospital","startDate":"2023-06-07","conditions":"Chronic Atrophic Gastritis","enrollment":60},{"nctId":"NCT06103526","phase":"NA","title":"Immunonutrition in ERAS Protocols in Gynecologic Oncology","status":"RECRUITING","sponsor":"National and Kapodistrian University of Athens","startDate":"2023-10-18","conditions":"Nutritional Deficiency, Gynecologic Cancer, ERAS","enrollment":200},{"nctId":"NCT05822518","phase":"NA","title":"Outcome of Perioperative Immune Enhancing Nutrition in Patients Undergoing Radical Cystectomy","status":"COMPLETED","sponsor":"Menoufia University","startDate":"2022-06-01","conditions":"Cancer, Bladder, Cystostomy; Complications","enrollment":42},{"nctId":"NCT06328283","phase":"","title":"The Diagnostic Efficacy of Glutamine Synthetaseand BCLAF1in Early Diagosis of Hepatocellular Carcinoma in Cirrhotic Patients","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2024-04-01","conditions":"Hepatocellular Carcinoma","enrollment":90},{"nctId":"NCT05551858","phase":"PHASE1, PHASE2","title":"Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis","status":"ACTIVE_NOT_RECRUITING","sponsor":"Georgetown University","startDate":"2022-11-17","conditions":"Safety Issues, Pain, Pancreas Fibrosis","enrollment":32},{"nctId":"NCT05371184","phase":"PHASE4","title":"Glutamine Role in Preventing Vaso-occlusive Crisis Among SCD Patients","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2022-01-04","conditions":"Sickle Cell Disease","enrollment":60},{"nctId":"NCT05833594","phase":"","title":"Whole-course Immunonutrition Combined With Chemoradiotherapy±ICIs for Local Advanced Patients With Inoperable Esophageal Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"Anhui Provincial Hospital","startDate":"2023-07-01","conditions":"Esophageal Squamous Cell Carcinoma, Chemoradiotherapy, Immunonutrition","enrollment":70},{"nctId":"NCT04560309","phase":"PHASE3","title":"Role of Glutamine as Myocardial Protector in Elective On-Pump CABG Surgery With Low EF","status":"COMPLETED","sponsor":"National Cardiovascular Center Harapan Kita Hospital Indonesia","startDate":"2021-01-01","conditions":"Coronary Artery Bypass, Cardiopulmonary Bypass, Coronary Artery Disease","enrollment":60},{"nctId":"NCT06065566","phase":"NA","title":"Effect of Parenteral Glutamine on Myocardial Injury and Inflammation Biomarkers","status":"COMPLETED","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2020-02-04","conditions":"Insufficiency;Cardiac","enrollment":56},{"nctId":"NCT02491931","phase":"NA","title":"Oral Glutamine in Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2013-01","conditions":"Ischemic Heart Disease","enrollment":28},{"nctId":"NCT05255328","phase":"NA","title":"Clinical Long Term Evaluation of Glutamine Supplement in MELAS Syndrome","status":"UNKNOWN","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2021-07-01","conditions":"MELAS Syndrome","enrollment":9},{"nctId":"NCT05592951","phase":"NA","title":"Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers","status":"COMPLETED","sponsor":"University of Memphis","startDate":"2022-09-30","conditions":"Safety, Tolerance","enrollment":40},{"nctId":"NCT01607879","phase":"PHASE2","title":"Use of β-hydroxy-β-methylbutyrate to Counteract Muscle Loss in Men With Prostate Cancer on Androgen Ablation","status":"COMPLETED","sponsor":"Medical College of Wisconsin","startDate":"2014-03","conditions":"Prostate Cancer","enrollment":48},{"nctId":"NCT00742157","phase":"PHASE4","title":"Evaluate the Efficacy and Safety Growth Hormone, Glutamine and Diet in Patients With Short Bowel Syndrome (SBS)","status":"TERMINATED","sponsor":"University of Nebraska","startDate":"2003-09-01","conditions":"Short Bowel Syndrome","enrollment":5},{"nctId":"NCT06004375","phase":"PHASE3","title":"THE EFFECT OF ARGININE AND GLUTAMINE ON COVID-19 PATIENTS OUTCOME: A RANDOMIZED CLINICAL TRIAL","status":"COMPLETED","sponsor":"Universitas Sriwijaya","startDate":"2021-05-01","conditions":"COVID-19","enrollment":20},{"nctId":"NCT03199638","phase":"NA","title":"Exercise Snacks and Glutamine to Improve Glucose Control in Adolescents With Type 1 Diabetes","status":"COMPLETED","sponsor":"Nemours Children's Clinic","startDate":"2016-04-01","conditions":"Diabetes Mellitus, Type 1, Autoimmune Diseases, Diabetes Mellitus","enrollment":14},{"nctId":"NCT02124941","phase":"PHASE1","title":"Glutamate-Glutamine Cycling (VCYC) During Cocaine Abstinence Using 1H-MRS","status":"COMPLETED","sponsor":"Yale University","startDate":"2014-02","conditions":"Cocaine Dependence, Healthy","enrollment":6},{"nctId":"NCT05934825","phase":"PHASE1, PHASE2","title":"Clinical Trial to Evaluate Safety and Efficiency of Mesenchymal Stem Cell in Patients With Hidradenitis Suppurativa","status":"UNKNOWN","sponsor":"Andalusian Network for Design and Translation of Advanced Therapies","startDate":"2022-10-26","conditions":"Hidradenitis Suppurativa","enrollment":30},{"nctId":"NCT04471415","phase":"PHASE1, PHASE2","title":"Study to Investigate DRP-104 in Adults With Advanced Solid Tumors","status":"TERMINATED","sponsor":"Dracen Pharmaceuticals, Inc.","startDate":"2020-08-31","conditions":"Advanced Solid Tumor, Non Small Cell Lung Cancer Metastatic","enrollment":61},{"nctId":"NCT05856188","phase":"NA","title":"Efficacy of Glutamine in Management of Radiation Mucositis","status":"UNKNOWN","sponsor":"Ain Shams University","startDate":"2022-01-01","conditions":"Radiation-Induced Mucositis","enrollment":40},{"nctId":"NCT03867214","phase":"PHASE4","title":"Effects of Oral Care With Glutamine on Oral Health, Oral Flora and Incidence of Pneumonia After Neurosurgery With Microbiome Analysis","status":"UNKNOWN","sponsor":"Yanzhao","startDate":"2019-01-01","conditions":"Oral Mucositis, Pneumonia","enrollment":100},{"nctId":"NCT03428217","phase":"PHASE2","title":"CANTATA: CB-839 With Cabozantinib vs. Cabozantinib With Placebo in Patients With Metastatic Renal Cell Carcinoma","status":"COMPLETED","sponsor":"Calithera Biosciences, Inc","startDate":"2018-04-24","conditions":"Advanced Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma","enrollment":444},{"nctId":"NCT04698681","phase":"","title":"NGS Screening Protocol to Detect Mutation of KEAP1 or NRF2/NFE2L2 Genes for the KEAPSAKE (CX-839-014) Trial","status":"TERMINATED","sponsor":"Calithera Biosciences, Inc","startDate":"2021-01-19","conditions":"Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung","enrollment":20},{"nctId":"NCT05106101","phase":"PHASE1","title":"L-glutamine Treatment in Patients With Diverticulosis","status":"COMPLETED","sponsor":"Emmaus Medical, Inc.","startDate":"2019-07-19","conditions":"Diverticulosis, Colonic","enrollment":9},{"nctId":"NCT05648422","phase":"NA","title":"Effect of the Nutritional Support System on Neuromotor Alterations in Patients With Cerebral Palsy","status":"UNKNOWN","sponsor":"Anahuac University","startDate":"2023-01-16","conditions":"Cerebral Palsy, Spastic, Malnutrition","enrollment":144},{"nctId":"NCT04840095","phase":"PHASE4","title":"Dynamic Connectivity Under Metabolic Constraints","status":"UNKNOWN","sponsor":"Massachusetts General Hospital","startDate":"2015-06-19","conditions":"Insulin Resistance, Healthy, Diet Modification","enrollment":80},{"nctId":"NCT05629975","phase":"NA","title":"Oral Nutritional Supplements in Treatment of Elderly Mild-to-Moderate COVID-19","status":"UNKNOWN","sponsor":"Shanghai Tongji Hospital, Tongji University School of Medicine","startDate":"2022-11-30","conditions":"Nutrition, Healthy","enrollment":150},{"nctId":"NCT03878381","phase":"EARLY_PHASE1","title":"Investigating the Wrinkle Reduction Potential of a Novel Compounded Skin Care Cream","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2019-04-01","conditions":"Skin Care","enrollment":10},{"nctId":"NCT05589012","phase":"","title":"Evaluation of Viral Replication by Tonate Virus (TONV) and Zika Virus (ZIKV), Within an ex Vivo Trophoblast and Placental Model","status":"UNKNOWN","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-11-01","conditions":"Zika Virus Infection","enrollment":8},{"nctId":"NCT05152849","phase":"PHASE2","title":"Efficacy, Safety, Tolerability of AXA1125 in Fatigue After COVID-19 Infection","status":"COMPLETED","sponsor":"Axcella Health, Inc","startDate":"2021-12-15","conditions":"Post-Acute Sequelae of SARS-CoV-2 (PASC) Infection","enrollment":41},{"nctId":"NCT05586646","phase":"NA","title":"Effect of IV Alanyl Glutamine on Healing of Pressure Ulcers in Critically Ill Patients","status":"UNKNOWN","sponsor":"Air Force Specialized Hospital, Cairo, Egypt","startDate":"2022-04-01","conditions":"Pressure Ulcer","enrollment":200},{"nctId":"NCT04152473","phase":"PHASE1","title":"Safety and Tolerability of Oral Proglumide for NASH","status":"COMPLETED","sponsor":"Georgetown University","startDate":"2019-12-13","conditions":"Nonalcoholic Steatohepatitis","enrollment":18},{"nctId":"NCT05569993","phase":"EARLY_PHASE1","title":"Glutamine and Traumatic Brain Injury","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-10-30","conditions":"Brain Injuries, Traumatic","enrollment":60},{"nctId":"NCT03057600","phase":"PHASE2","title":"Study of CB-839 in Combination w/ Paclitaxel in Participants of African Ancestry and Non-African Ancestry With Advanced Triple Negative Breast Cancer (TNBC)","status":"COMPLETED","sponsor":"Calithera Biosciences, Inc","startDate":"2017-05-01","conditions":"Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer","enrollment":52},{"nctId":"NCT04265534","phase":"PHASE2","title":"KEAPSAKE: A Study of Telaglenastat (CB-839) With Standard-of-Care Chemoimmunotherapy in 1L KEAP1/NRF2-Mutated, Nonsquamous NSCLC","status":"TERMINATED","sponsor":"Calithera Biosciences, Inc","startDate":"2020-07-24","conditions":"Non-Small Cell Lung Cancer, Non-squamous Non-small-cell Lung Cancer, Non-Squamous Non-Small Cell Neoplasm of Lung","enrollment":40},{"nctId":"NCT03163667","phase":"PHASE2","title":"CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)","status":"COMPLETED","sponsor":"Calithera Biosciences, Inc","startDate":"2017-09-06","conditions":"Clear Cell Renal Cell Carcinoma","enrollment":69},{"nctId":"NCT04880187","phase":"PHASE2","title":"Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis","status":"UNKNOWN","sponsor":"Axcella Health, Inc","startDate":"2021-05-07","conditions":"Non Alcoholic Steatohepatitis (NASH)","enrollment":273},{"nctId":"NCT03445221","phase":"PHASE2, PHASE3","title":"Preoperative Immunonutrition and Cardiac Patients","status":"COMPLETED","sponsor":"Assiut University","startDate":"2018-08-01","conditions":"Cardiac Function","enrollment":60},{"nctId":"NCT04684381","phase":"PHASE4","title":"Pharmacokinetics and Safety of Endari (L-glutamine) in Sickle Cell Disease Patients","status":"COMPLETED","sponsor":"Emmaus Medical, Inc.","startDate":"2021-01-04","conditions":"Sickle Cell Disease, Pharmacokinetics","enrollment":13},{"nctId":"NCT02071862","phase":"PHASE1","title":"Study of the Glutaminase Inhibitor CB-839 in Solid Tumors","status":"COMPLETED","sponsor":"Calithera Biosciences, Inc","startDate":"2014-02","conditions":"Solid Tumors, Triple-Negative Breast Cancer, Non Small Cell Lung Cancer","enrollment":210},{"nctId":"NCT05406882","phase":"PHASE2, PHASE3","title":"The Effects of Probiotics Combined With Glutamine in the Prevention and Treatment of Radiation Proctitis","status":"UNKNOWN","sponsor":"West China Hospital","startDate":"2022-04-15","conditions":"Radiation Proctitis, Probiotics, Glutamine","enrollment":176},{"nctId":"NCT02838979","phase":"PHASE2","title":"Trial of Oral Glutamine on Mitochondrial Function in CKD","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-02-25","conditions":"Cardiovascular Disease, Sarcopenia, Endothelial Dysfunction","enrollment":11},{"nctId":"NCT01952847","phase":"PHASE3","title":"Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2014-07-10","conditions":"Advanced Cancers","enrollment":77},{"nctId":"NCT02053350","phase":"PHASE2","title":"Alanyl-glutamine Supplementation of Standard Treatment for C. Difficile Infection","status":"TERMINATED","sponsor":"University of Virginia","startDate":"2015-04","conditions":"Clostridium Difficile Infection","enrollment":7}],"_emaApprovals":[],"_faersSignals":[{"count":68,"reaction":"NAUSEA"},{"count":59,"reaction":"FATIGUE"},{"count":53,"reaction":"PAIN"},{"count":45,"reaction":"ARTHRALGIA"},{"count":43,"reaction":"DIARRHOEA"},{"count":43,"reaction":"HEADACHE"},{"count":41,"reaction":"DRUG INEFFECTIVE"},{"count":39,"reaction":"DIZZINESS"},{"count":39,"reaction":"SICKLE CELL ANAEMIA WITH CRISIS"},{"count":38,"reaction":"WEIGHT DECREASED"}],"administration":{"route":"Oral"},"crossReferences":{"chemblId":"CHEMBL3707366"},"_approvalHistory":[{"date":"20240708","type":"ORIG","sponsor":"NOVITIUM PHARMA","applicationNumber":"ANDA215647"}],"publicationCount":3513,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Endari","NSC-143503","oral L-glutamine"],"phase":"marketed","status":"active","brandName":"L-glutamine","genericName":"L-glutamine","companyName":"Jun Gong, MD","companyId":"jun-gong-md","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":4,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T07:02:36.841606+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}